Request Demo
Last update 25 Oct 2025
Recombinant human growth hormone(Shenzhen Kexing Biotech Co. Ltd.)
Last update 25 Oct 2025
Overview
Basic Info
Drug Type Hormone |
Synonyms Sai Gao Lu, 赛高路 |
Target |
Action agonists |
Mechanism GHR agonists(Growth hormone receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (24 Jun 2002), |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with Recombinant human growth hormone(Shenzhen Kexing Biotech Co. Ltd.)CTRI/2013/09/003957
A prospective Phase III, Multicentre, Randomised, Open Label Study to Evaluate the Comparitive Safety and Efficacy of Recombinant Human Growth Hormone (rhGH) of USV with Eutropin in the Treatment of Pre-pubertal Children (4 to 12 years) with Growth Hormone Deficency
IRCT1138901181414N11
Comparison of the short & long term effects and side effects of Samen recombinant human growth hormone & NOVO growth hormone in children with growth hormone deficiency: double-blind randomized clinical trial study
ISRCTN13681882
Short term recombinant human Growth Hormone administration increases strength and power, but does it improve sporting performance in anabolic-androgenic steroid users?
100 Clinical Results associated with Recombinant human growth hormone(Shenzhen Kexing Biotech Co. Ltd.)
Login to view more data
100 Translational Medicine associated with Recombinant human growth hormone(Shenzhen Kexing Biotech Co. Ltd.)
Login to view more data
100 Patents (Medical) associated with Recombinant human growth hormone(Shenzhen Kexing Biotech Co. Ltd.)
Login to view more data
100 Deals associated with Recombinant human growth hormone(Shenzhen Kexing Biotech Co. Ltd.)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Growth hormone deficiency | China | 24 Jun 2002 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free